NCT07032116Not yet recruiting
YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1
Evidence-based Evaluation of Yiqi Jiangzhuo Huoxue Tongluo Method in Delaying the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study 1
Source: ClinicalTrials.gov · Last updated 22 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In order to reduce the clinical demand for kidney dialysis rate of Diabetic Kidney Disease（DKD） patients, a bidirectional cohort study of 4472 patients with DKD (Qi deficiency and collateral stasis syndrome) was carried out based on a preliminary DKD cohort of 13,000 patients. The exposure factor was supplementing and reducing the kidney turbidity-Huoxue Tongluo method represented by the addition and subversion of Shenzhuo prescription, and the incidence of end-stage renal disease was the main therapeutic index. Follow-up was conducted for 2 years
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 4472 (estimated)
- First submitted
- 8 Apr 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 31 Jul 2028
- Lead sponsor
- Liu Hongfang
- Diseases
- Chronic kidney disease
- NCT number
- NCT07032116
What you commit to
- Study type: Observational
- Planned participants: 4472
- From 1 Aug 2025 to the primary completion date, 31 Jul 2028
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 6 Tumor patients undergoing radiotherapy, chemotherapy or targeted therapy.
Other illness
- 1 combined with other clear renal diseases, such as polycystic kidney disease, glomerulonephritis, renal tumor, etc. ;
- 2 patients with a history of recurrent genitourinary tract infection ;
- 3 combined with cardiovascular and cerebrovascular, digestive, respiratory, urinary, immune system serious diseases or mental diseases ;
- 5 Patients with type 1 diabetes.
Other
- 4 currently in pregnancy, lactation, or pregnancy plan women ;
Who the study is looking for
- 1 in line with Western medicine diagnostic criteria for type 2 diabetic kidney disease ;
- 2 18-80 years old, regardless of gender ;
- 3 eGFR \> 15ml / ( min · 1.73m2 ) ; the eGFR was calculated according to the chronic kidney disease epidemiology collaboration equation ( CKD-EPI ).
- 4 In line with the diagnostic criteria of qi deficiency and collateral stasis syndrome in traditional Chinese medicine ;
- 5glycosylated hemoglobin ( HbA1c ) between 7-10 % ;
- 6 blood pressure ≤ 160 / 100mmHg ;
- 7 to sign the informed consent ;
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guang'anmen Hospital，China Academy of Chinese Medical Sciencescancel Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Dongzhimen Hospital of BeijingUniversity of Chinese Medicine Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| The Affiliated Hospital to ChangChun University of Chinese Medicinecancel Coordinator of this site? Confirm its status | Changchun | China | Unknown status |
| the First Affiliated Hospital of Sun Yat-sen University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| Tianjin Medical University Chu Hsien-I Memorial Hospital Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.